CASE STUDY: LATE DETECTION OF FACTITIOUS DISORDER-MUNCHAUSSEN’S SYNDROME WITH FEIGNED SCHIZOPHRENIA
Vie Cheong Thong*#, Deshvin Kaur Amanjit Singh**, Sze Hung Chua**
*Department of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia;
**Hospital Mesra Bukit Padang, Kota Kinabalu, Sabah;
#Department of Psychiatry and Mental Health, Hospital Lahad Datu, Lahad Datu, Sabah
Abstract
Introduction: The Authors present a case illustrating factitious disorder, who was previously diagnosed as schizophrenia for 2 years, with a comorbidity of depressive disorder (unspecified) and obsessive-compulsive disorder.
Case Presentation: The factitious presentation involved exaggeration of symptoms, demanding and challenging behavior towards medical personnel, prolonging of sick role by refusing necessary intervention. Diagnosis of schizophrenia complicated patient’s condition when poly-pharmacy was introduced. The element of deception too provided difficulty in clinician to identify other comorbid psychiatric issue of depression and Obsessive Compulsive Disorder (OCD), with the suspicion of Borderline Personality Disorder.
Conclusion: We emphasize the importance of recognizing possible signs of deception through looking at the atypical presentation throughout the treatment course and consequences following the misdiagnosis.
Prevalence of Bipolar Disorder and Schizophrenia in Patients Diagnosed with Multiple Sclerosis or Neuromyelitis Optica: A Meta-Analysis
Authors: Roovam Balasubramaniam1, Suneesa Som Sak1, Kai Li Teh1, Leong Tung Ong1
Presenter: Roovam Balasubramaniam
Affiliation: 1Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur.
Introduction: Multiple sclerosis (MS) and neuromyelitis optica (NMO) are chronic autoimmune disorders primarily affect the central nervous system, marked by inflammation, demyelination, and neurodegeneration. Studies have shown that psychiatric illnesses are common among MS and NMO patients. Hence, this study aims to investigate the prevalence of bipolar disorder and schizophrenia in patients with MS and NMO.
Methods: We identified relevant studies via search engines (PubMed, Embase, Ovid SP, and SCOPUS) from inception up until to 31st March 2024. The prevalence was calculated as proportion. The pooled prevalence with 95% CI was calculated using the random-effects generic inverse variance method. Statistical analysis conducted using Cochrane Review Manager v5.4.
Results: This meta-analysis included 39 studies involving a total of 277,872 patients. The pooled prevalence rate of bipolar disorder in patients with MS and NMO was 4% (95% CI 3-4%). Subgroup analysis demonstrated that South America has the highest prevalence of bipolar disorder among MS and NMO patients at 14% (95% CI 6-21%), followed by Asia-Pacific 13% (95% CI 8-18%), North America 6% (95% CI 4-7%) and Europe 1% (95% CI 1-1%). Conversely, the pooled prevalence rate of schizophrenia was 1% (95% CI 1-1%). Based on subgroup analysis, the highest prevalence of schizophrenia among MS and NMO patients was tied between Asia Pacific and South America, both at 2% (95% CI 1-3%) and 2% (95% CI 1-5%) respectively. This was followed by Europe and North America, each with a 1% (95% CI 0-1%) prevalence of schizophrenia among MS and NMO patients.
Conclusion: This meta-analysis highlights the risks of developing bipolar disorder and schizophrenia in patients with MS and NMO. Hence, patients with MS and NMO should be routinely screened for severe psychiatric illness to ensure early diagnosis and prompt treatment which may improve the prognosis and quality of life.
Prevalence of Neuropsychiatric Presentations Observed in Patients Diagnosed with Neurosyphilis: A Meta-Analysis
Authors: Suneesa Som Sak1, Kai Li Teh1, Roovam Balasubramaniam1, Leong Tung Ong1
Presenter: Suneesa Som Sak
Affiliation: 1Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur.
Introduction: Neurosyphilis, a severe complication of syphilis arising from Treponema palliduminfection, is also known as the "great mimicker". This is due to its extensive spectrum of neuropsychiatric symptoms encompassing cognitive impairment, psychiatric symptomatology and neurological deficits. Hence, this study aims to investigate the prevalence of neuropsychiatric presentations observed in patients diagnosed with neurosyphilis.
Methods: We identified relevant studies via search engines (PubMed, Embase, Ovid SP, and SCOPUS) from inception up until to 30th April 2024. The prevalence was calculated as proportion. The pooled prevalence with 95% CI was calculated using the random-effects generic inverse variance method. Statistical analysis conducted using Cochrane Review Manager v5.4.
Results: Thirty-nine studies reported neuropsychiatric presentations in neurosyphilis with a combined sample size of 2356 patients. The pooled prevalence rate of HIV co-infection in neurosyphilis patients was 37% (95%CI,23%-51%;16 studies). The total number of neuropsychiatric presentations investigated were 29. The most prevalent neurological presentations were fatigue (31%,95%CI,21%-42%;2 studies), ocular symptoms (29%,95%CI,19%-40%;23 studies), cognitive impairment (25%,95%CI,17%-33%;12 studies), memory deterioration (22%,95%CI,13%-30%;6 studies), and headache (22%,95%CI,15%-29%;24 studies). Other notable symptoms included paresis (18%,95%CI,13%-23%;19 studies), dizziness (17%,95%CI,11%-23%;6 studies), dementia (17%,95%CI,6%-27%;6 studies), delirium (15%,95%CI,8%-23%;10 studies), sensory abnormalities (15%,95%CI,9%-22%;10 studies), speech disorder (15%,95%CI,2%-21%;17 studies), dysphagia (14%,95%CI,1%-29%;2 studies), otic symptoms (14%,95%CI,8%-20%;15 studies) meningism (13%,95%CI,7%-20%;10 studies), lancinating pain (12%,95%CI,4%-20%;5 studies), and confusion (12%,95%CI,6%-17%;8 studies). The prevalence of psychiatric disorders among patients diagnosed with neurosyphilis was 22%(95%CI,11%-32%;7 studies). The prevalence for each psychiatric symptoms reported in neurosyphilis was as followed: psychosis 17%(95%CI,5%-28%;4 studies), behavioural disorders 11%(95%CI,5%-17%;8 studies), mood disorders 13% (95%CI,6%-20%;6 studies), delusion 9% (95%CI,2%-16%;6 studies), and hallucination 8% (95%CI,1%-17%;5 studies).
Conclusion: This meta-analysis highlights the neuropsychiatric presentations are commonly seen in patients with neurosyphilis. Hence, physicians should consider neurosyphilis as one of the differential diagnoses when patients presenting with neuropsychiatric symptoms.
UNMASKING ANXIETY:
A BAFFLING JOURNEY TO DECODE STIFF-PERSON SYNDROME
Zi Xin Teh1, Chian Hui Yeoh1
1Department of Internal Medicine, Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia1
INTRODUCTION
Stiff-person syndrome (SPS) is a rare progressive neurological disorder characterised by muscle stiffness, rigidity with episodic spams involving axial muscles, resulting in falls and ambulation impairment. These episodes can be triggered by stressful and emotional stimuli. Psychiatric symptoms frequently accompany this disorder and patients are often first seen by psychiatrists.
CASE PRESENTATION
A 46-year-old female presented with chronic low back pain and recurrent falls. Frequent falls and unpredictability of the disease lead to multiple hospital visits for anxiety attacks. She was initially managed by the psychiatry team and started on benzodiazepines. Symptoms progression with frequent acute exacerbation left her incapacitated and unable to move from her bed, leading to medical team attention. Her initial neurological examination revealed spastic hypertonia and hyperreflexia with preserved muscle strength in all extremities. Laboratory results were negative or within normal limits including white cell count, complement C3 and C4, antinuclear antibody (ANA), erythrocyte sedimentation rate (ESR), C-reactive protein, thyroid function test and human immunodeficiency virus (HIV). Serum creatinine kinase was raised. Computed tomography (CT) of brain and cervical spine magnetic resonance imaging (MRI) were unremarkable. Baclofen and clonazepam were started for symptomatic relief. However, there was no significant improvement in her stiffness. During her fourth week in hospital, serum anti-glutamic acid decarboxylase (GAD) antibody returned positive with a titre of 195.2 IU/ml. She received intravenous immunoglobulin (IVIG) 2g/kg over 5 days with continued improvement. Two months post discharge, she was able to mobilise using walking frame.
CONCLUSION
SPS is a rare disorder and may present with co-existing psychiatric symptoms. Although rare, SPS should always be included in the differential diagnosis for patients presenting with a psychogenic movement disorder.
Recognition, Assessment, and Management of Tardive Dyskinesia: A Southeast Asian Expert Consensus
Roongroj Bhidayasiri1, Kok Yoon Chee2, Jin Kiat Ang3, Roger Ho4, Ahmad Shahir bin Mawardi5, Adhi Wibowo Nurhidayat6, Pongsatorn Paholpak7, Pornjira Pariwatcharakul8, Thitima Sanguanvichaikul9, Eng Khean Ung10, Natalia Dewi Wardani11, Brian Yeo12, Gilbert Madriaga13, Koh Jia Juan Tammy13, Christoph U. Correll14,15
1Chulalongkorn Centre of Excellence for Parkinson’s Disease & Related Disorders (ChulaPD) Chulalongkorn University, Bangkok, Thailand, 2Department of Psychiatry and Mental Health, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia, 3Department of Psychiatry, Hospital Sultan Abdul Aziz Shah, UPM, Serdang, Selangor, Malaysia, 4Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 5Department of Neurology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia, 6Department of Psychiatry, Faculty of Medicine, UIN Syarif Hidayatullah Jakarta, South Tangerang, Indonesia, 7Department of Psychiatry, Khon Kaen University, Khon Kaen, Thailand, 8Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 9Department of Psychiatry, Somdet Chaopraya Institute of Psychiatry, Bangkok, Thailand, 10Adam Road Medical Centre, Singapore, 11Department of Psychiatry, Diponegoro University, Central Java, Indonesia,12Mount Elizabeth Medical Centre, Singapore, Singapore, 13Regional Medical Affairs Department, Mitsubishi Tanabe Pharma Singapore, Singapore, 14Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA, 15Department of Child and Adolescent Psychiatry, Charité – Universitätsmedizin Berlin, Berlin, Germany
Introduction: Tardive dyskinesia (TD), a movement disorder induced by dopamine receptor blocking agents (DRBAs), is not well recognized by most clinicians in Southeast Asia (SEA). Thus, guidance on assessment and management of TD is warranted. This consensus study aimed to provide recommendations on the assessment and management of TD in SEA.
Methods: Thirteen experts from the fields of neurology, neuropsychiatry, and psychiatry from Southeast Asian countries participated in the consensus development via the Modified RAND-UCLA Appropriateness Method, consisting of a review of literature, drafting clinical scenarios with ratings (Likert Scale: 1-9), followed by a face-to-face meeting that led to the recommendations.
Results: The expert panel recommended that patients taking DRBAs should be screened for TD every 6 months (Median [Mdn]: 9; Interquartile Range [IQR]: 9,9), regardless of the risk (Mdn: 8; IQR: 8,9). In cases where face-to-face physical consultation were not feasible, the panel agreed that TD could also be diagnosed (Mdn: 8; IQR: 7,9) or assessed (Mdn: 8; IQR: 8,9) during telemedicine video appointments. The panel also recommended vesicular monoamine transporter-2 inhibitors as the first-line treatment if available (Mdn: 9; IQR: 8,9). Other treatment options that were accessible in the region were also suggested, with consensus against anticholinergics.
Conclusion: These regional consensus recommendations provide practical guidance intended for busy clinicians in their assessment and management of patients with TD.
A case report of psychosis as an expression of focal impaired awareness seizure in elderly patient
Norili Farhana Ahmad Saberi1, Nur Syamimi Che Md Azim1
(Department of Psychiatry, Hospital Tanah Merah, 17500 Tanah Merah, Kelantan)
Formerly known as complex partial seizures, focal impaired awareness seizures (FIAS) are defined as focal seizures that originate in one hemisphere of the brain and are associated with an impairment of consciousness. FIAS is frequently misdiagnosed as a functional psychiatric disorder due to its affective, behavioral, and cognitive symptoms, especially when there is absence of motor manifestation of seizure or that part of history was omitted. This case portrayed a case of a geriatric patient with FIAS presenting as psychotic and behavioral disturbance.
This case illustrates a 68 year old lady with a background history of hypertension and hyperlipidemia presented with acute behavioral disturbance associated with auditory hallucinations and persecutory delusion. Detailed history revealed that she has been experiencing recurrent fitting episodes which was described as tonic-clonic seizure with impaired awareness 2 to 3 times a month since about 20 years ago. Notwithstanding, her recurrent episodes of fitting she was still able to fully function independently as well as managing the household. There were no episodes of affective or behavioral disturbance. This year though, the fitting episode became more frequent in which she was also reported to have cognitive decline with episodes of riotous behavioral disturbance and psychosis that lead her to first medical and psychiatry contact.
A thorough clinical assessment is crucial, especially in geriatric patients that exhibits symptoms of psychosis, altered mental state, with concomitant chronic medical conditions. For patients with atypical presentations of seizure disorders, a high index of suspicion is necessary to effectively manage and avoid future seizure episodes, especially when there is no conclusive diagnostic instrument available at the time of seizure activity.
Unveiling Neurological Intrigue: From Anxiety to Brain Tumor - A Case Report
Siti Nur Najibah Fauzi1, Nor Asyikin Fadzil1
Background: It is uncommon for psychiatric symptoms to be considered a manifestation of a brain tumor in the absence of neurological signs. Diagnosing a brain tumor can be challenging when a patient presents with another medical illness that has a similar psychiatric manifestation.
Case presentation: This case report details a 58-year-old male who presented to the emergency department with two weeks of symptoms of excessive worry, agitation, dysphoric mood, and worsening cognitive function as his first psychiatry encounter. Regular practice in psychiatry, where excluding organicity is a must in diagnosing any anxiety disorder, revealed a high thyroid function test in this patient. Hence, he was diagnosed and managed as an anxiety disorder secondary to hyperthyroidism. After one month on carbimazole, repeated thyroid function test turned normal. Despite treatment with a selective serotonin reuptake inhibitor (SSRI), benzodiazepine, and normalization of thyroid function tests, his anxiety symptoms worsened. As the condition progressed, neurological symptoms and signs appeared, leading to neuroimaging that revealed an unexpected intracranial mass at the left fronto-parietal region which had not been investigated during the initial presentation. The patient was referred to a neurosurgical team, and the tumor was surgically removed, resulting in a total subsidence of his anxiety symptoms.
This case report describes a 58-year-old male who presented to the emergency department with a two-week history of excessive worry, agitation, dysphoric mood, and declining cognitive function, marking his first encounter with psychiatric care. In line with standard psychiatric practice, which requires ruling out organic causes when diagnosing anxiety disorders, the patient underwent a thyroid function test, which revealed hyperthyroidism. Consequently, he was diagnosed with anxiety disorder secondary to hyperthyroidism and started on carbimazole. After one month of treatment, his thyroid function returned to normal. Despite the use of a selective serotonin reuptake inhibitor (SSRI), benzodiazepine, and the normalization of his thyroid function, his anxiety symptoms worsened. As the illness progressed, neurological symptoms and signs emerged, prompting neuroimaging that revealed an unexpected intracranial mass in the left fronto-parietal region, which had not been investigated during the initial evaluation. The patient was referred to a neurosurgical team, and the tumor was surgically removed, resulting in the complete resolution of his anxiety symptoms.
Conclusion:This case highlights the challenges in detecting destructing operable causes of illness in patients presented with psychiatry symptoms, especially when the medical condition mimics the psychiatry presentation. It highlights the importance of considering brain imaging in the initial psychiatric evaluation, even though imaging services are readily accessible. This is especially crucial for patients presenting with sudden onset of psychiatric symptoms, not responding to psychiatry medication or late onset of illness without apparent life stressors.
Keywords: Brain tumor, Psychiatry symptom, Case report
1Department of Psychiatry, School of Medical Sciences, Universiti Sains Malaysia, Jalan Raja Perempuan Zainab II, 16150 Kubang Kerian, Kelantan.
Corresponding author:
Nor Asyikin Fadzil, Department of Psychiatry, School of Medical Sciences, Universiti Sains Malaysia, Jalan Raja Perempuan Zainab II, 16150 Kubang Kerian, Kelantan .
“AM I DEAD? A CASE OF COTARD’S SYNDROME IN A WOMAN WITH SUBCLINICAL HYPOTHYROIDISM.”
Shereen Kaur Manocha 1, Suriati Mohamed Saini 1,2, Shalisah binti Sharip 1,2, Low Chee Koon 1, Kanit Tha Deang 1, Prashantini Sivaram 1, Muhammad Haziq Hawi 1
1 Department of Psychiatry, Hospital Canselor Tuanku Muhriz, Jalan Yaacob Latif, Cheras, 56000, Kuala Lumpur.
2Department of Psychiatry, Faculty of Medicine, University Kebangsaan Malaysia.
ABSTRACT
Introduction : A 44-year-old Malay female presented to the psychiatry clinic with a two-week history of nihilistic delusions in which she negated body parts and existence. There was an element of delusion of misidentification as she believed that there was someone else who was her and she was even unable to recognize her own reflection.
Case Presentation : She had auditory hallucinations, delusions of control, delusional mood, thought alienation, disorganised speech and behaviour. She experienced a low mood, low appetite and low energy but no hopelessness, worthlessness or suicidal ideation. Apart from psychotic and mood symptoms, she experienced fluctuations in her consciousness and memory. Her cognition had reduced to a point whereby she was unable to remember the simple act of using a toothbrush and was perplexed whenever she had to make decisions for the use of toilet amenities for various needs. Vital signs and physical examinations were unremarkable. A Montreal Cognitive Assessment (MoCA) test scored 14/30, reflecting moderate cognitive impairment which improved a week later with a score of 22/30. Her Frontal Assessment Battery (FAB) score of 14/18 was within the normal range. Blood investigations showed increased thyroid-stimulating-hormone (TSH), Complement 4(C4), C-reactive protein and a positive antinuclear antibodies titre of 1:320. Contrast-Enhanced CT(CECT), MRI and the EEG were normal. Lumbar puncture showed an increase in CSF protein. Our final diagnosis, a dual-diagnosis, was made – depressive disorder with psychotic features due to hypothyroidism and acute delirium with mixed levels of activity. Recommencement of antipsychotics and levothyroxine as well as optimization of antidepressant resulted in resolution of psychotic and depressive symptoms. However, the persistence of cognitive issues warranted a neuropsychological assessment by a clinical psychologist which revealed mild cognitive impairment.
Conclusion : A key learning point is that hypothyroidism can manifest as neuropsychiatric symptoms that affect mood, cognition and behaviour. Early diagnosis and treatment with thyroid replacement are crucial in hypothyroidism-related neuropsychiatry disorder.
(300 words)
Keywords : Delirium, Cotard Delusion, Delusion of Misidentification, Hypothyroidism, Cognition
Randomized Controlled Trial Comparing the Effects of Deep Breathing Exercises, Aromatherapy, and Psychospiritual Therapy on electroencephalogram (EEG), Biometrics; Heart Rate Variability (HRV) signals Among Malaysian Workers
Dr Chong Siew Koon1, Dr. Nurnadiah Zamri2, Dr. Samhani Ismail2, Dr. Azimah Ismail2, Dr. Norsuhaily Abu Bakar2, Pn Siti Nurani Hj Hassan2
1Psychiatry and Mental Health Hospital Kuala Lumpur
2Faculty of Informatics and Computing, Universiti Sultan Zainal Abidin, Besut Campus, 22200 Besut, Terengganu, Malaysia
Abstract:
This study compares the efficacy of relaxation techniques using an objective approach by examining client responses to various therapies through electroencephalogram (EEG) and Heart Rate Variability (HRV) signals. Conducted in Kuala Terengganu, Malaysia, the study includes therapies such as aromatherapy, deep breathing exercises (DBE), and psychospiritual (ruqyah), alongside a control group. Key metrics such as HRV coherence ratio, EEG delta wave activity, Power Spectral Density (PSD), and duration of calmness are used to evaluate the efficacy of these interventions. Results indicate that DBE and aromatherapy are most effective in promoting relaxation, followed by psychospiritual therapy.
Methodology:
This Randomised Control Trial compares three forms of relaxation techniques—DBE, aromatherapy, and psychospiritual—using EEG and biometric recordings, including HRV and PSD. A control group not receiving any form of psychotherapy is also included. Recordings of the aforementioned parameters are taken before and after the implementation of relaxation techniques. Participants attend a single session lasting approximately 30 minutes. DASS-21, BDI, and BAI are used to ensure that participants have comparable baseline values. Inclusion criteria include those who consent to participate whilst those excluded are clients who score high on mental health screening which require prompt psychiatric referral and aid. The DBE focuses on deep breathing exercises, aromatherapy uses Melaleuca cajuputi oil extract, while psychospiritual therapy utilizes ruqyah recitations. A total of 152 participants completed the study over approximately two months. The effectiveness of each therapy versus control is measured by the duration of calmness, as recorded by EEG delta wave activity, HRV, and PSD analysis.
Results:
DBE achieved sustained calmness with an average duration of 250 seconds on EEG recording, followed by aromatherapy with an average of 200 seconds. Key findings include the high effectiveness of DBE, which showed the highest coherence levels and the longest duration of slow-wave activity, indicating strong potential for enhancing well-being and stress management. Aromatherapy demonstrated the greatest induction of deep relaxation, supported by the highest PSD value for delta waves.
Discussion:
These results suggest the potential for incorporating DBE and aromatherapy into therapeutic interventions for mental health management. These practices could also benefit workplaces by alleviating stress and enhancing relaxation among employees, leading to a more productive and satisfied workforce. Future studies should investigate combining different relaxation techniques within the same session for synergistic effects, explore additional therapies beyond the current ones, extend the duration of therapy sessions to assess long-term benefits, and test these interventions across various occupational groups to ensure their effectiveness in diverse work environments.
Title:
The Landolt Phenomenon and Forced Normalization: A Comprehensive Case Report of De Novo Psychosis Unveiled Following Seizure Resolution
Dr Chong Siew Koon1, Dr Chee Kok Yoon1 Dr Kenny Ong Kheng Yee1, Dr Ng Khian Boon1 Dr Chee Jiunn Heng1, Dr Sivanathini Visvanathan1, Dr Nurdillah Idris2
1 Psychiatry and Mental Health, Hospital Kuala Lumpur
2 Neuroradiology Department, Hospital Kuala Lumpur
Abstract:
The intricate relationship between seizures and schizophrenia-like psychoses has been a topic of longstanding interest. Throughout medical history, clinicians and psychiatrists have documented infrequent occurrences wherein the resolution of intractable seizures coincides with the emergence of abnormal behaviors, including hallucinations and delusions. Landolt phenomenon is a term suggesting a potential antagonistic dynamic between these two clinical entities. This case report provides a thorough examination of such phenomena in a specific clinical context.
The case:
Miss CM, a 36-year-old Chinese woman, has had seizures since age 11, experiencing 5-10 monthly episodes characterized by tonic-clonic movements and postictal drowsiness, with no significant developmental delays. Despite being slightly slower than her siblings and only marginally successful in exams, she maintained a functional life until 2017 when her seizures became more frequent, affecting her job as a clerk. Despite treatment with Leviracetam, Carbamazepine, and Zonisamide, seizure control was incomplete. An MRI in 2019 revealed left hippocampal sclerosis, left hemicerebral atrophy, and parietotemporal encephalomalacia.
In January 2021, Miss CM underwent left fronto-temporal craniotomy to address the epileptic lesion, which successfully resolved her seizures. However, by August 2021, she developed new psychiatric symptoms, including paranoia and auditory hallucinations, leading to a diagnosis of de-novo psychosis following epilepsy surgery. Despite initial improvement with Risperidone, it became clear that she required long-term psychiatric treatment, as attempts to discontinue the medication led to recurrent psychotic symptoms.
Neuroimagings:
A pre-operative Magnetic Resonance Imaging (MRI) conducted in October 2019 disclosed T2WI/FLAIR hyperintense signal within left hippocampus with associated hippocampal atrophy . Additionally, there is also atrophy of the left hemicerebral extended into the temporal neocortex, frontoparietal lobes, insular region, and thalamus. Presence of cystic encephalomalacia of the left parietal lobe and posterior superior temporal gyrus, along with left lateral ventricle ex-vacuo dilatation, suggested sequelae from a history of repeated prolonged seizures. The overall MR findings support a dual pathology encompassing left hippocampal sclerosis and left hemicerebral atrophy with left parietotemporal encephalomalacia.
Post operative MRI finding 2023: MRI post Anterior Temporal Lobectomy (ATL) surgery. Axial T1W image (a) showing evidence of left ATL. Coronal (c) and sagittal (b) FLAIR images surgical cavity (arrow) with cystic encephalomalacia of adjacent temporal lobe
Conclusion:
In conclusion, this case report highlights the complex interplay between seizure control and the emergence of schizophrenia-like psychoses, exemplified by Miss CM's clinical course following epilepsy surgery. The successful resolution of her long-standing seizures was paradoxically accompanied by the onset of new psychiatric symptoms, underscoring the potential antagonistic relationship between epileptic and psychotic phenomena, as suggested by the Landolt phenomenon. This case emphasizes the need for vigilant long-term psychiatric monitoring in patients undergoing epilepsy surgery, particularly when structural brain abnormalities are involved.
Huntington’s Disease vs Functional Parkinsonism: Diagnostic Conundrum Deciphered By DaT Imaging
Lukmanul Hakim Misron1, Siti Nor Fadhlina Misron2, Gouri Das3, Nur Khuzaimah binti Kasmat3
1Nuclear Medicine, Hospital Kuala Lumpur
2Hospital Permai
3Nuclear Medicine, Hospital Sultanah Aminah
Introduction:
For centuries, the conundrum faced by psychiatrists and neurologists is to differentiate between organic and functional movement disorder. With the advancement of medical technology, DaT (Dopamine Transporter) Imaging has been a useful tool to assist in ruling in or out diseases associated with reduced dopamine uptake in basal ganglia region indicating the damage to the cells. As basal ganglia involved in both the initiation up desired movement and inhibiting the undesired movement, the damage may cause the haphazard facilitation and inhibition of movement out of patient’s will. As Dat Imaging just find it roots in Malaysia past 3 three years, the case report illustrates the game changing role of Dat Imaging in Malaysia context.
Case Presentation:
A 47-year-old optometrist presented with involuntary hand movement that gradually worsening for two years. When she first presented, the movement was mistakenly diagnosed as Functional Parkinsonism. Due to the absence of other parkinsonism features and the variable amplitude and frequency of the hands movement, she was referred to neuropsychiatry with the suspiciousness of functional movement disorder. However, with the history of 3 successive generations of choreiform movement which presented around 40 years of age, the suspiciousness of Huntington’s disease was inevitable. The MRI brain was reported as normal. However the DAT Imaging shows reduced dopamine uptake at bilateral caudate and putamen consistent with Huntington’s Disease. She was treated with Risperidone and the chorea improved.
Conclusion:
The case illustrates the conundrum faced by psychiatrist in Malaysia as diagnosis determined the direction of management which is completely different between Huntington’s Disease and Functional Parkinsonism. DAT Imaging in Malaysia is a bless such as it helps the psychiatrist to decipher the codes in differentiating both conditions and treat the patients accurately.
Role Of Methylphenidate In Reversing The Cognitive Impairment Due Prolactinoma Attenuated By Paradoxical Cabergoline Effect
Phoong Bo Yuan1, Lau Kit Mun2, Lee Czen Yhi 3, Siti Nor Fadhlina Misron2
1Psychiatry Department, Hospital Kajang
2Hospital Permai
3 Psychiatry Department, Hospital Pulau Pinang
Introduction:
Methylphenidate has been known to improve cognitive impairment. However its role in treating the cognitive impairment associated with pituitary macroadenoma or paradoxical Cabergoline effect is still unknown. This case illustrates the usefulness of Methylphenidate when used in the aforementioned condition. The success of the treatment shed a ray of hope for the conditions to be treated in the future.
Case Presentation:
A 42-year-old mechanic presented was referred by the endocrinologist for cognitive impairment since 2019. He had been treated with Cabergoline since 2020 after being diagnosed with prolactinoma. MRI showed features suggestive of pituitary macroadenoma. His initial prolactin was more than 300 times of normal upper limit and currently has reduced to only double of the normal upper limit. Wife and patients both noticed that patient has been forgetful and inattentive since 2019. The symptoms worsened since Cabergoline initiated. NuCOG showed that the score of both attention and memory domain were below 2 standard deviation.
He was diagnosed with Cognitive Impairment Due Prolactinoma Attenuated By Paradoxical Cabergoline Effect and started on Methylphenidate. The NuCOG improved with attention score was above 2 standard deviation and the memory above 1 standard deviation. Subjective input from wife was that he does not misplace his belongings since tha initiation of Methylphenidate.
Conclusion:
Prolactinoma has been known to be the culprit for cognitive impairment. In normal and expected circumstances, Cabergoline which is a dopaminergic agent helps to reduce serum prolactin level and improve the cognitive impairment. However, this patient is unfortunate to develop the rare paradoxical reaction on the cognition. This case illustrates the advantage of Methylphenidate in treating the cognitive impairment associated with both prolactinoma and paradoxical effect of Cabergoline.
Spirituality as an Executive Function of the Brain: A Neuroscience Perspective for a Holistic
Approach to patient-based Clinical Management Preferences EBM and Personalized
Medicine
Taufiq Pasiak
Research Centre for Regenerative Medicine and Neuroscience-UPN Veteran Jakarta
Spirituality has long been recognized as an essential element in human health. Several recent
studies have shown the positive role of spirituality on health; mental, emotional, and physical
well-being, and even in the amelioration of disease. However, understanding and measuring
aspects of spirituality in the medical world is often unstructured and complex to measure
objectively. In addition, there are still many different understandings among medical experts.
Evidence-based medicine (EBM), especially the aspect of patient preference and Personalized
Medicine, opens up opportunities to incorporate spirituality in Medicine. Personalized
Medicine emphasizes the importance of designing treatments based on each patient's unique
profile. By incorporating aspects of spirituality, we can offer more comprehensive and holistic
care while improving patient satisfaction and medication adherence.
Scientific evidence shows that spirituality can reduce stress, increase resilience, improve
quality of life, and support recovery from various illnesses. Studies show that patients who
engage in spiritual practices have better health outcomes and higher levels of life satisfaction.
Research also reveals that spiritual support can reduce symptoms of depression and anxiety,
improve medication adherence, and accelerate the recovery process.
This article introduces the concept of Transcendental Executive Function (FET) as an extension
of the previously recognized Executive Function or Conventional Executive Function (CEF),
which integrates dimensions of spirituality to create a more holistic, observable, and
measurable approach in clinical practice. Combining FET with the brain's executive function
framework allows us to identify and utilize the significant contributions of spirituality in
clinical health and healing. Brain structures such as the prefrontal cortex, anterior cingulate
cortex, basal ganglia, hippocampus, amygdala, thalamus, and parietal lobes support executive
functions, decision-making, planning, emotional regulation, and attentional control.
Integrating spirituality in the context of brain executive function improves the quality of
healthcare and reinforces a patient-centered and holistic medical approach. This article
proposes a comprehensive framework combining FET with brain executive function to
improve clinical interventions and patient health outcomes. With a deeper understanding of
how spirituality affects executive function, we can develop more effective and personalized
treatment strategies encompassing all aspects of a patient's health.
Keywords: Spirituality, executive function, neuroscience
Neuropsychiatry Malaysia ©
Copyright © 2024 Neuropsychiatry Malaysia - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.